Targovax ASA has reported promising disease-free survival (DFS) data from Tg01 in resected pancreatic cancer.
Up To Date
Latest News
Six years after the European Commission created the world's first bioeconomy strategy and action plan, it...
T cells target a bacterial variant of a human enzyme promoting autoimmune diseases such as Multiple...
Genentech's new partner Affimed NV has halted two blood cancer programmes with its tetravalent bispecific T...
Oxford-based immunoncology player Sitryx Therapeutics Ltd. (Oxford, U.K.) has bagged $30m in a Series A...
British gene therapy developer Orchard Therapeutics will go IPO on Nasdaq, according to SEC filings. The...